Tumor regression and curability of preclinical neuroblastoma models by PEGylated SN38 (EZN-2208), a novel topoisomerase I inhibitor (Q39668506)
Jump to navigation
Jump to search
scientific article published on 11 August 2010
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Tumor regression and curability of preclinical neuroblastoma models by PEGylated SN38 (EZN-2208), a novel topoisomerase I inhibitor |
scientific article published on 11 August 2010 |
Statements
1 reference
Tumor regression and curability of preclinical neuroblastoma models by PEGylated SN38 (EZN-2208), a novel topoisomerase I inhibitor (English)
1 reference
1 reference
Domenico Ribatti
1 reference
Fabio Pastorino
1 reference
Monica Loi
1 reference
Puja Sapra
1 reference
Pamela Becherini
1 reference
Michele Cilli
1 reference
Laura Emionite
1 reference
Lee M Greenberger
1 reference
Ivan D Horak
1 reference
11 August 2010
1 reference
1 reference
16
1 reference
19
1 reference
4809-4821
1 reference
Identifiers
1 reference
1 reference